Controlling HCV in Switzerland: running against the clock

Andreas Cerny; Raoul Blindenbacher; Alberto Moriggia

doi:10.4414/smw.2019.20005

Viewpoint

Vol. 149 No. 1112 (2019)

Controlling HCV in Switzerland: running against the clock

Andreas Cerny
Raoul Blindenbacher
Alberto Moriggia

DOI: https://doi.org/10.4414/smw.2019.20005
Cite this as:: Swiss Med Wkly. 2019;149:w20005
Published: 24.03.2019

References

Swiss Hepatitis Strategy 2014-2030. Time to Act Now! Process Paper - A Living Document. http://www.hepatitisschweiz.ch/files/Dokumente/Process_Paper_2nd_version_final.pdf. 2015 (Retrieved 23.11.2018).
Swiss Federal Office of Public Health. [Situation Analysis of Hepatitis B and C in Switzerland.] Bern: Federal Office of Public Health; 2017.
Blach S, Schaetti C, Bruggmann P, Negro F, Razavi H. Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland. Swiss Med Wkly. 2019;149:w20026. doi:https://doi.org/10.4414/smw.2019.20026
World Health Organisation. Combating Hepatitis B and C to reach elimination by 2030, Advocacy brief. Geneva: WHO; 2016. Available at: https://www.who.int/hepatitis/publications/hep-elimination-by-2030-brief/en/
Faissol DM, Griffin PM, Swann JL. Bias in Markov models of disease. Math Biosci. 2009;220(2):143–56. doi:.https://doi.org/10.1016/j.mbs.2009.05.005
Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, et al. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions. Swiss Med Wkly. 2019;149:w14694. doi:.https://doi.org/10.4414/smw.2019.14694
Elrod JK, Fortenberry JL, Jr. The hub-and-spoke organization design: an avenue for serving patients well. BMC Health Serv Res. 2017;17(S1, Suppl 1):457. doi:.https://doi.org/10.1186/s12913-017-2341-x
Blindenbacher R, Bidjan N. The Black Box of Governmental Learning. The Learning Spiral – A Concept to Organize Learning in Governments. Washington DC: World Bank; 2010. ISBN 978-0-8213-8453-4 — ISBN 978-0-8213-8474-9.

Publication image

How to Cite

1.

Cerny A, Blindenbacher R, Moriggia A. Controlling HCV in Switzerland: running against the clock. Swiss Med Wkly [Internet]. 2019 Mar. 24 [cited 2025 Feb. 12];149(1112):w20005. Available from: https://smw.ch/index.php/smw/article/view/2593

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Christine Ludz, Guido Stirnimann, David Semela, Joachim Mertens, Andreas E. Kremer, Magdalena Filipowicz Sinnreich, Christiane Sokollik, Christine Bernsmeier, Solange Bresson-Hadni, Valérie McLin, Nathalie Rock, Christian Braegger, Carsten Posovszky, Pascal Müller, Matthias Cremer, Andrea De Gottardi, Antonio Galante, Raoul Furlano, Franziska Righini-Grunder, Björn Becker, Stephan Böhm, Klaas Heyland, Andreas Nydegger, Costanzo Limoni, Diego Vergani, Giorgina Mieli-Vergani, Claudia Di Bartolomeo, Andreas Cerny, Benedetta Terziroli Beretta-Piccoli, Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study , Swiss Medical Weekly: Vol. 153 No. 8 (2023)
Rainer Fretz, Francesco Negro, Philip Bruggmann, Daniel Lavanchy, Andrea De Gottardi, Isabelle Pache, Virginie Masserey Spicher, Andreas Cerny, Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection , Swiss Medical Weekly: Vol. 143 No. 1920 (2013)
Nicolas Goossens, Stefano Bellentani, Andreas Cerny, Jean-Francois Dufour, François R. Jornayvaz, Joachim Mertens, Alberto Moriggia, Beat Muellhaupt, Francesco Negro, Homie Razavi, David Semela, Chris Estes, Nonalcoholic fatty liver disease burden – Switzerland 2018–2030 , Swiss Medical Weekly: Vol. 149 No. 5152 (2019)
Andrea Bregenzer, Philip Bruggmann, Erika Castro, Alberto Moriggia, Madeleine Rothen, Maria Christine Thurnheer, Pietro Vernazza, Claude Scheidegger, Hepatitis C virus elimination in Swiss opioid agonist therapy programmes – the SAMMSU cohort , Swiss Medical Weekly: Vol. 151 No. 0910 (2021)
Eleni Moschouri, Gloria Salemme, Adriana Baserga, Andreas Cerny, Ansgar Deibel, Beat Müllhaupt, Marie-Anne Meier, Christine Bernsmeier, Marie Ongaro, Francesco Negro, Marielle Grosjean, Olivier Clerc, Patrizia Künzler-Heule, David Semela, Gabriel Hobi, Felix Stickel, Adeline Mathieu, Elise Mdawar-Bailly, Mohamed Faouzi, Darius Moradpour, Montserrat Fraga, Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis , Swiss Medical Weekly: Vol. 154 No. 6 (2024)
Lorenz Kuske, Armand Mensen, Beat Müllhaupt, Francesco Negro, David Semela, Darius Moradpour, Pierre Jean Malé, Markus H Heim, Raffaele Malinverni, Andreas Cerny, Jean-Francois Dufour, Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma , Swiss Medical Weekly: Vol. 142 No. 3132 (2012)
Darius Moradpour, Andreas Cerny, Markus H. Heim, Hubert E. Blum, Hepatitis C: an update , Swiss Medical Weekly: Vol. 131 No. 2122 (2001)
Andreas Cerny, Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically! , Swiss Medical Weekly: Vol. 145 No. 5152 (2015)

[1] Swiss Hepatitis Strategy 2014-2030. Time to Act Now! Process Paper - A Living Document. http://www.hepatitisschweiz.ch/files/Dokumente/Process_Paper_2nd_version_final.pdf. 2015 (Retrieved 23.11.2018).

[2] Swiss Federal Office of Public Health. [Situation Analysis of Hepatitis B and C in Switzerland.] Bern: Federal Office of Public Health; 2017.

[3] Blach S, Schaetti C, Bruggmann P, Negro F, Razavi H. Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland. Swiss Med Wkly. 2019;149:w20026. doi:https://doi.org/10.4414/smw.2019.20026

[4] World Health Organisation. Combating Hepatitis B and C to reach elimination by 2030, Advocacy brief. Geneva: WHO; 2016. Available at: https://www.who.int/hepatitis/publications/hep-elimination-by-2030-brief/en/

[5] Faissol DM, Griffin PM, Swann JL. Bias in Markov models of disease. Math Biosci. 2009;220(2):143–56. doi:.https://doi.org/10.1016/j.mbs.2009.05.005

[6] Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, et al. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions. Swiss Med Wkly. 2019;149:w14694. doi:.https://doi.org/10.4414/smw.2019.14694

[7] Elrod JK, Fortenberry JL, Jr. The hub-and-spoke organization design: an avenue for serving patients well. BMC Health Serv Res. 2017;17(S1, Suppl 1):457. doi:.https://doi.org/10.1186/s12913-017-2341-x

[8] Blindenbacher R, Bidjan N. The Black Box of Governmental Learning. The Learning Spiral – A Concept to Organize Learning in Governments. Washington DC: World Bank; 2010. ISBN 978-0-8213-8453-4 — ISBN 978-0-8213-8474-9.